BioSig Technologies, Inc. (STEX)
NASDAQ · Financial Services
BioSig Technologies, Inc. EBITDA 2020–2024
BioSig Technologies, Inc. annual/quarterly ebitda history and growth rate from 2020 to 2024. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- BioSig Technologies, Inc. ebitda for the quarter ending June 30, 2024 was -5.2 M, a 51.53% decrease year-over-year.
- BioSig Technologies, Inc. ebitda for the twelve months ending June 30, 2024 was -23.4 M, a 14.55% decrease year-over-year.
- BioSig Technologies, Inc. annual ebitda for 2024 was -12.7 M, a 54.98% decrease from 2023.
- BioSig Technologies, Inc. annual ebitda for 2023 was -28.2 M, a 4.37% increase from 2022.
- BioSig Technologies, Inc. annual ebitda for 2022 was -27.0 M, a 18.79% decrease from 2021.
- BioSig Technologies, Inc. annual ebitda for 2021 was -33.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioSig Technologies, Inc. EBITDA — FAQ
BioSig Technologies, Inc. (STEX) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see STEX's ebitda history?
The chart and table above show BioSig Technologies, Inc.'s ebitda by year and by quarter, including the growth rate.